Genenta Science Statistics
Total Valuation
Genenta Science has a market cap or net worth of $60.82 million. The enterprise value is $48.95 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Genenta Science has 19.15 million shares outstanding. The number of shares has increased by 1.60% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.15M |
| Shares Change (YoY) | +1.60% |
| Shares Change (QoQ) | +2.61% |
| Owned by Insiders (%) | 27.00% |
| Owned by Institutions (%) | 7.44% |
| Float | 12.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.28 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.20, with a Debt / Equity ratio of 0.62.
| Current Ratio | 13.20 |
| Quick Ratio | 12.64 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.15% and return on invested capital (ROIC) is -29.55%.
| Return on Equity (ROE) | -60.15% |
| Return on Assets (ROA) | -26.59% |
| Return on Invested Capital (ROIC) | -29.55% |
| Return on Capital Employed (ROCE) | -43.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$785,995 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.70% in the last 52 weeks. The beta is 0.58, so Genenta Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -45.70% |
| 50-Day Moving Average | 3.32 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 46.96 |
| Average Volume (20 Days) | 8,227 |
Short Selling Information
| Short Interest | 1,176 |
| Short Previous Month | 1,440 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.13M |
| Pretax Income | -10.22M |
| Net Income | -10.22M |
| EBITDA | -10.09M |
| EBIT | -10.13M |
| Earnings Per Share (EPS) | -$0.55 |
Full Income StatementBalance Sheet
The company has $20.75 million in cash and $8.87 million in debt, giving a net cash position of $11.88 million or $0.62 per share.
| Cash & Cash Equivalents | 20.75M |
| Total Debt | 8.87M |
| Net Cash | 11.88M |
| Net Cash Per Share | $0.62 |
| Equity (Book Value) | 14.23M |
| Book Value Per Share | 0.74 |
| Working Capital | 22.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.39 million and capital expenditures -$12,007, giving a free cash flow of -$11.32 million.
| Operating Cash Flow | -11.39M |
| Capital Expenditures | -12,007 |
| Free Cash Flow | -11.32M |
| FCF Per Share | -$0.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
